Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02576990 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) |
| First Submitted : | October 14, 2015 |
| First Submitted that Met QC Criteria : | October 14, 2015 |
| First Posted : | October 15, 2015 (Estimate) |
| Results First Submitted : | May 26, 2020 |
| Results First Submitted that Met QC Criteria : | June 11, 2020 |
| Results First Posted : | June 24, 2020 |
| Last Update Submitted that Met QC Criteria : | July 25, 2023 |
| Last Update Posted : | July 27, 2023 |